Informations techniques
Exploitant
Laboratoires PROSTRAKAN PHARMA
Présentation
DROLEPTAN 2,5 mg/ 1ml, solution injectable (IV) B/10 - CIP 561 122-8
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
nrWHbhYhxVBcheUL